Mark Weinreb, CEO and Chairman of the Board at BioRestorative Therapies, Inc. (BRTX), bought 12,500 shares at $0.25 ($3K) on 2019-08-27, disclosed to the SEC on 2019-08-29.
Open-market purchase of $3k BRTX by CEO and Chairman of the Board. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 2,500 | $625 | 19.2% |
| 2 | $0.26 | 2,500 | $650 | 20.0% |
| 3 | $0.26 | 2,500 | $650 | 20.0% |
| 4 | $0.26 | 2,500 | $658 | 20.2% |
| 5 | $0.27 | 2,500 | $675 | 20.7% |
| Total | $0.26 avg | 12,500 |
| $3K |
| 100% |
| Filing → |